about
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1882-9410
@en
name
Alessandra Cataldo
@ast
Alessandra Cataldo
@en
Alessandra Cataldo
@es
Alessandra Cataldo
@nl
type
label
Alessandra Cataldo
@ast
Alessandra Cataldo
@en
Alessandra Cataldo
@es
Alessandra Cataldo
@nl
prefLabel
Alessandra Cataldo
@ast
Alessandra Cataldo
@en
Alessandra Cataldo
@es
Alessandra Cataldo
@nl
P106
P1153
56342952100
P31
P496
0000-0002-1882-9410